Michael Cooreman
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Gastroenterology top 5%
Papers in
- Epidemiology 12
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 5
- Hepatology 10
- Hepatitis C virus research 9
- Co-authors
- Wilma P. Paulij (3 shared papers)Geert Leroux‐Roels (2 shared papers)K. J. Hengels (2 shared papers)Beat Weidmann (1 shared paper)Neil S. Ryder (1 shared paper)Kai Lin (1 shared paper)Choi-Lai Tiong-Yip (1 shared paper)Sue Ma (1 shared paper)
- Journals
- Journal of Hepatology (5 papers)Gastroenterology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Biomedical Science (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
Michael Cooreman
22 papers receiving 930 citations
Michael Cooreman's Hit Papers
Peers
Comparison fields: 5 of 89
- Hepatology 321
- Gastroenterology 73
- Epidemiology 409
- Biochemistry 76
- Pharmaceutical Science 38
Countries citing papers authored by Michael Cooreman
This map shows the geographic impact of Michael Cooreman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cooreman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cooreman more than expected).
Fields of papers citing papers by Michael Cooreman
This network shows the impact of papers produced by Michael Cooreman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cooreman. The network helps show where Michael Cooreman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Cooreman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 165 | |
| 2 | 2002 | 157 | |
| 3 | 2006 | 140 | |
| 4 | 2010 | 109 | |
| 5 | 1993 | 84 | |
| 6 | 2017 | 51 | |
| 7 | 1999 | 46 | |
| 8 | Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD Hit paper breakdown → | 2025 | 41 |
| 9 | 2024 | 37 | |
| 10 | 2024 | 30 | |
| 11 | 2014 | 30 | |
| 12 | 1996 | 27 | |
| 13 | 2001 | 12 | |
| 14 | 2013 | 11 | |
| 15 | 1997 | 10 | |
| 16 | 2013 | 7 | |
| 17 | 1988 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 1990 | 1 |
About Michael Cooreman
Michael Cooreman is a scholar working on Epidemiology, Hepatology, Surgery, Molecular Biology and Gastroenterology, having authored 24 papers that have together received 967 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (5 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Gastroesophageal reflux and treatments (2 papers), Lymphatic Disorders and Treatments (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Hepatology (321 citations), Gastroenterology (73 citations), Epidemiology (409 citations), Biochemistry (76 citations) and Pharmaceutical Science (38 citations). Michael Cooreman has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Wilma P. Paulij, Geert Leroux‐Roels, K. J. Hengels, Beat Weidmann, Neil S. Ryder, Kai Lin, Choi-Lai Tiong-Yip, Sue Ma, Sven Francque and Brahm Goldstein. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Antimicrobial Agents and Chemotherapy, Journal of Biomedical Science and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.